Sort   by:  
 Page size 
ProteomicsHexokinase 2 is a transcriptional targetHexokinase 2 is a transcriptional target and a positive modulator of AHR signalling and a positive modulator of AHR signalling
The Aryl Hydrocarbon Receptor (AHR) regulates the expression of numerous genes in response to activation by agonists including xenobiotics. Although it is well appreciated that environmental signals and cell intrinsic features may modulate this transcriptional response, how it is mechanistically ach...
ORGANISM(S): Homo sapiens (Human) 
2022-05-31 | PXD028992 | Pride
Human  iosteosarcoma  hexokinase 2  ahr 
ProteomicsIntegrated liver-secreted and plasma proteomics approaches identify a predictive model that stratifies MASH in bariatric patients
Background & Aims Obesity is a major risk factor for metabolic associated steatotic liver disease (MASLD) which can progress from metabolic associated steatotic liver (MASL) to metabolic associated steatohepatitis (MASH). There are currently no effective and validated screening tools to stratify obe...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD052798 | Pride
Masld Hepatokine Apasha Masl Liver-secreted proteome Metabolic associated steatohepatitis Biomarker Plasma proteomics Mash Nash Nafld 
UnknownChronic pain and associated factors in remote work during the COVID-19 pandemic in Brazil.
Not available
S-EPMC10695055 | biostudies-literature
ProteomicsMASH human liver - secreted proteome
An approximate 1 cm3 wedge liver biopsy was collected from the left lobe of the liver during surgery. The liver was cut into two portions. One portion was placed in formalin and transported to TissuPathTM (Mount Waverley, Victoria), paraffin embedded and processed for histological analysis. Samples ...
ORGANISM(S): Homo sapiens (Human) 
2025-03-25 | PXD052787 | Pride
Liver Human Mash Nash 
ProteomicsIntegrated liver-secreted and plasma proteomics approaches identify a predictive model that stratifies MASH in bariatric patients
Background & Aims Obesity is a major risk factor for metabolic associated steatotic liver disease (MASLD) which can progress from metabolic associated steatotic liver (MASL) to metabolic associated steatohepatitis (MASH). There are currently no effective and validated screening tools to stratify obe...
ORGANISM(S): Homo sapiens (Human) 
2025-04-14 | PXD052784 | Pride
Masld Hepatokine Apasha Masl Liver-secreted proteome Metabolic associated steatohepatitis Biomarker Plasma proteomics Mash Nash Nafld 
UnknownRole of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis.
Not available
S-EPMC5925711 | biostudies-literature
UnknownComparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites.
Not available
S-EPMC4731938 | biostudies-literature
UnknownStrain analysis of cardiac chambers in individuals with temporal lobe epilepsy.
Not available
S-EPMC12371644 | biostudies-literature
UnknownUpdating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres.
Not available
S-EPMC10065236 | biostudies-literature
UnknownHow To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide.
Not available
S-EPMC7449218 | biostudies-literature
Sort   by:  
 Page size